Intravenously administered immune globulin for the treatment of infection-associated hemophagocytic syndrome.
Infection-associated hemophagocytic syndrome is an unusual disease with a high mortality rate. A variety of treatment modalities have been used with limited success. We report three patients with infection-associated hemophagocytic syndrome successfully treated with intravenously administered immune globulin.